Related Experiment Video

Updated: Jun 27, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K

Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a

Yago Nieto1, Pinaki Banerjee2,3, Indreshpal Kaur2

  • 1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ynieto@mdanderson.org.

Nature Medicine
|June 26, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.3K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K

Related Experiment Videos

Last Updated: Jun 27, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

21.3K
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Articles linked to this work by shared authors, journal, and citation graph.

Mitochondrial Complex I at the Crossroads of NK cell Dysfunction in Glioblastoma.

Cancer discovery·2026

Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma.

Blood advances·2026

Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

Blood advances·2026

Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826).

Blood advances·2026

Transnasal endoscopy for eosinophilic esophagitis surveillance in adolescents with mild autism spectrum disorder: A single-center case series.

JPGN reports·2026

A consensus-based guideline for personalized bacteriophage therapy.

Nature medicine·2026

Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma.

Nature medicine·2026

Sex-specific biological aging clocks across organs and omics.

Nature medicine·2026

Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial.

Nature medicine·2026

EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse.

Nature medicine·2026

Liquid biopsy for early detection of pancreatic ductal adenocarcinoma.

Nature medicine·2026

Extracellular vesicle-based therapies in IBD: immunomodulation, regeneration, and translation.

Frontiers in immunology·2026

Immune cell-derived exosomes in cancer: double-edged mechanisms of antitumor immunity and tumor progression.

Frontiers in immunology·2026

Review-Nanozyme-Based Immunosensors and Immunoassays: Recent Developments and Future Trends.

Journal of the Electrochemical Society·2026

The transformative potential of lipid nanoparticles tailored for acute myeloid leukemia immunotherapy.

Frontiers in immunology·2026

Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.

Frontiers in oncology·2026

Recent Advances in Artificial Intelligence for Endoscopic and Multimodal Assessment of Inflammatory Bowel Disease: A Review.

International journal of general medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us